Free White Paper: How Risk Management Tools can Improve Product Quality in Today’s Rapid Lifecycles
With the product lifecycle moving so fast, many organizations may ask the question, "how can we effectively measure quality?"
With the product lifecycle moving so fast, many organizations may ask the question, "how can we effectively measure quality?" What can an organization do to keep up with this new pace of business while ensuring the visibility that quality deserves? The answer is Risk Management.
In this white paper learn about how Risk Management provides the framework for handling adverse events in a systematic way, the elements of Risk Management and how they help to identify, prevent and mitigate risk throughout an organization and how Risk Management will allow an organization to reduce the risk of product failure in design.
http://www.etq.com/eu/pharmtech/whitepaper-risklifecycle/
Flexible-Dose Development Strategies for Today's Clinical Landscape - Executive Summary
January 8th 2025This executive summary focuses on dose-flexible manufacturing strategies and their role in drug development. Dose flexibility is increasingly important for early clinical studies, particularly in areas such as pediatric medicines and oncology. However, flexible dosing strategies are often neglected or not prioritized early in development. This presentation will focus on technical strategies that can help anticipate appropriate timing for implementation and how to do so cost effectively while adhering to required timelines.
Molecular Properties of PROTACs and the Relationship to Formulation Design
December 20th 2024Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.
